Hisamitsu Pharmaceutical Co., Inc.

November 22, 2021

Products to solve issues for living in Space and living on Earth

"Fixpace®"

Notification to be used in the International Space Station

Hisamitsu Pharmaceutical Co., Inc. (Head Office: Tosu, Saga; President: NAKATOMI Kazuhide; hereinafter " Hisamitsu Pharmaceutical") announces that "Fixpace®" proposed by Hisamitsu Pharmaceutical was selected as a daily necessity for "Ideas for addressing the issues along with the solution that will apply to both living in space and living on Earth" solicited by Japan Aerospace Exploration Agency (hereinafter "JAXA"), and will be used in the International Space Station (hereinafter "ISS").

■Background of Development

In the "Space Life Story Book *" published by JAXA, "reducing the loss and scattering of objects" in zero gravity space is mentioned as one of the life issues in space. To solve this issue, Hisamitsu Pharmaceutical has developed "Fixpace®" using the patch technology that has been developed over many years.

■About "Fixpace®"

"Fixpace®" is a product to hold pens, knives or forks by simply attaching them on "Fixpace®" applied on a wall or table. In addition, "Fixpace®" can be used repeatedly since adhesive material which can be re-attached is used.

Through "Fixpace®", Hisamitsu Pharmaceutical will try to develop products to solve issues for living in Space and living on Earth using our developed technology.

※:A list of issues and inconvenience in space life published by JAXA

https://iss.jaxa.jp/med/images/71532_story.pdf

Hisamitsu Pharmaceutical has always listened to the voices from customers and focused on drug discovery / development and improvement of formulation technology based on "the Customer-first Principle". Going forward, Hisamitsu Pharmaceutical will continue to carry out business activities based on the patch technology developed over the years, and contribute to improving the quality of life of people around the world.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Hisamitsu Pharmaceutical Co. Ltd. published this content on 22 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 November 2021 01:03:05 UTC.